391 G (Carbidopa and Levodopa Extended Release 50 mg / 200 mg)
Pill with imprint 391 G is Purple, Elliptical / Oval and has been identified as Carbidopa and Levodopa Extended Release 50 mg / 200 mg. It is supplied by Global Pharmaceuticals.
Carbidopa/levodopa is used in the treatment of parkinson's disease; restless legs syndrome; neuroleptic malignant syndrome; gtp-ch deficiency and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Carbidopa/levodopa 50 mg / 200 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 391 G
Carbidopa and Levodopa Extended Release
- Imprint:
- 391 G
- Strength:
- 50 mg / 200 mg
- Color:
- Purple
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Dopaminergic antiparkinsonism agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Global Pharmaceuticals
- Inactive Ingredients:
- hydroxypropyl cellulose
magnesium stearate
FD&C Blue No. 2
FD&C Red No. 40
Note: Inactive ingredients may vary.
More about carbidopa/levodopa
- Carbidopa/levodopa Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- 54 Reviews
- Drug class: dopaminergic antiparkinsonism agents
Consumer resources
- Carbidopa and levodopa
- Carbidopa and levodopa enteral
- Carbidopa and Levodopa Orally Disintegrating Tablets
- Carbidopa and Levodopa Sustained-Release Tablets
- Carbidopa and Levodopa Tablets
- ... +4 more
Other brands: Sinemet, Rytary, Sinemet CR, Parcopa, Duopa
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
